Manager × security

Parkman Healthcare Partners LLC DXCM holdings history

Who else holds this security? →

DEXCOM INC · CUSIP 252131107 · CIK 1777015

This is the oldest quarter open without an account, so changes against the quarter before it are withheld. Sign in to see them.
Citable facts

As of 2026-06-30, Parkman Healthcare Partners LLC reported 534.77K DXCM (shares), valued at $36.02M, or 3.70% of its reported non-derivative portfolio. Filed 2026-08-14.

Verify history & sources →
Portfolio weight and quantity history
Reported portfolio weight
3.70%
Shares
534.77K
534,767
Reported value
$36.02M
USD

Shares decreased 22.48%; reported value decreased 16.86%, and weight changed -0.79 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q2 20263.70%534,767SEC filing ↗Filed Aug 14, 2026
Q1 20264.49%689,822SEC filing ↗Filed May 15, 2026
Q4 20253.71%587,475SEC filing ↗Filed Feb 17, 2026
Q3 20251.27%171,628SEC filing ↗Filed Nov 14, 2025
Q2 20252.28%225,875SEC filing ↗Filed Aug 14, 2025
Q1 20251.06%130,367SEC filing ↗Filed May 15, 2025
Q4 20240.81%78,550SEC filing ↗Filed Feb 14, 2025
Q3 20240.60%70,588SEC filing ↗Filed Nov 14, 2024
Q2 20242.42%156,855SEC filing ↗Filed Aug 14, 2024
Q1 20242.92%171,665SEC filing ↗Filed May 15, 2024
Q4 20233.96%225,615SEC filing ↗Filed Feb 14, 2024

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q4 20233.96%225,615$28.00MThe prior quarter is outside the free window. Sign in for the comparison.SEC filing ↗
Filed Feb 14, 2024
Q1 20242.92%171,665$23.81MShares decreased 23.91%; reported value decreased 14.95%, and weight changed -1.04 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 15, 2024
Q2 20242.42%156,855$17.78MShares decreased 8.63%; reported value decreased 25.31%, and weight changed -0.50 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2024
Q3 20240.60%70,588$4.73MShares decreased 55.00%; reported value decreased 73.39%, and weight changed -1.82 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 14, 2024
Q4 20240.81%78,550$6.11MShares increased 11.28%; reported value increased 29.09%, and weight changed +0.21 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 14, 2025
Q1 20251.06%130,367$8.90MShares increased 65.97%; reported value increased 45.74%, and weight changed +0.25 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 15, 2025
Q2 20252.28%225,875$19.72MShares increased 73.26%; reported value increased 121.47%, and weight changed +1.22 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2025
Q3 20251.27%171,628$11.55MShares decreased 24.02%; reported value decreased 41.43%, and weight changed -1.01 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 14, 2025
Q4 20253.71%587,475$38.99MShares increased 242.30%; reported value increased 237.62%, and weight changed +2.44 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 17, 2026
Q1 20264.49%689,822$43.32MShares increased 17.42%; reported value increased 11.11%, and weight changed +0.78 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 15, 2026
Q2 20263.70%534,767$36.02MShares decreased 22.48%; reported value decreased 16.86%, and weight changed -0.79 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2026
Parkman Healthcare Partners LLC · DEXCOM INC

Take these holdings further.

This page includes 11 of 11 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

+ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

get_institutional_portfolio
{"cik":"1777015","quarter":"2026Q2","cusip":"252131107"}

get_institutional_manager_history
{"cik":"1777015","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.